Posaconazole Tablet, Delayed Release
Product Images NDC 72319-023

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 72319-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by I3 Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container (Container)

Label for Posaconazole delayed-release tablets, 100 mg strength, oral dosage form. The package contains 60 tablets. Labeler is i3 Pharmaceuticals, LLC, Warminster, PA. The label includes storage instructions, a barcode, and a QR code. The product NDC is 72319-023-02.*

FDA Label Image

Structure.jpg (Structure.jpg)

Chemical structure of posaconazole, a triazole antifungal active ingredient, depicted with multiple aromatic rings, fluorine atoms, and heterocyclic components connected by various bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.